Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer.
J Clin Oncol. 2011 Dec 10;29(35):4662-8. doi: 10.1200/JCO.2011.36.1352. Epub 2011 Nov 7.
J Clin Oncol. 2011.
PMID: 22067389
Free PMC article.
Clinical Trial.
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer.
Maluf FC, Leiser AL, Aghajanian C, Sabbatini P, Pezzulli S, Chi DS, Wolf JK, Levenback C, Loh E, Spriggs DR.
Maluf FC, et al.
Int J Gynecol Cancer. 2006 May-Jun;16(3):1165-71. doi: 10.1111/j.1525-1438.2006.00454.x.
Int J Gynecol Cancer. 2006.
PMID: 16803501
Clinical Trial.
Item in Clipboard
Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31-7453 in patients with advanced solid tumors.
Dupont J, Bienvenu B, Aghajanian C, Pezzulli S, Sabbatini P, Vongphrachanh P, Chang C, Perkell C, Ng K, Passe S, Breimer L, Zhi J, DeMario M, Spriggs D, Soignet SL.
Dupont J, et al.
J Clin Oncol. 2004 Aug 15;22(16):3366-74. doi: 10.1200/JCO.2004.12.007.
J Clin Oncol. 2004.
PMID: 15310782
Clinical Trial.
Item in Clipboard
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
Diefenbach CS, Gnjatic S, Sabbatini P, Aghajanian C, Hensley ML, Spriggs DR, Iasonos A, Lee H, Dupont B, Pezzulli S, Jungbluth AA, Old LJ, Dupont J.
Diefenbach CS, et al.
Clin Cancer Res. 2008 May 1;14(9):2740-8. doi: 10.1158/1078-0432.CCR-07-4619.
Clin Cancer Res. 2008.
PMID: 18451240
Clinical Trial.
Item in Clipboard
Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors.
Tew WP, Gordon M, Murren J, Dupont J, Pezzulli S, Aghajanian C, Sabbatini P, Mendelson D, Schwartz L, Gettinger S, Psyrri A, Cedarbaum JM, Spriggs DR.
Tew WP, et al.
Clin Cancer Res. 2010 Jan 1;16(1):358-66. doi: 10.1158/1078-0432.CCR-09-2103. Epub 2009 Dec 22.
Clin Cancer Res. 2010.
PMID: 20028764
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.
Aghajanian C, Soignet S, Dizon DS, Pien CS, Adams J, Elliott PJ, Sabbatini P, Miller V, Hensley ML, Pezzulli S, Canales C, Daud A, Spriggs DR.
Aghajanian C, et al.
Clin Cancer Res. 2002 Aug;8(8):2505-11.
Clin Cancer Res. 2002.
PMID: 12171876
Clinical Trial.
Item in Clipboard
Cite
Cite